•$Belite Bio (BLTE.US)$+17.49% (announces that LBS-008 an orally administered tablet has been granted Fast Track Designation by the U.S. Food and Drug Administration for the treatment of STGD1)
•$Pfizer (PFE.US)$-1.1% (reported a first-quarter profit of $1.62 per share, 15 cents a share above estimates. Revenue topped forecasts as well. The drugmaker cut its full-year outlook due to an accounting change)
Analyst comments:
•$Carvana (CVNA.US)$-4.8% (downgraded to Equal Weight from Overweight at Wells Fargo)
BullRunner : Thanks for a very informative info.
SarumanWise : Agreed, very useful information, especially the context. Appreciate the effort![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)
71263800 SarumanWise : Push up upup push $40
70171859 BullRunner : E ex